Signals
Sugar substitutes were sold as metabolic shortcuts. The evidence is getting harder to ignore
A new review and meta-analysis in Current Atherosclerosis Reports found that non-nutritive sweeteners may not be metabolically inert. Across randomised trials and observational evidence, artificial and low-calorie sweeteners were linked to signals of disrupted glucose-insulin regulation, microbiome changes and higher cardiometabolic risk. The policy problem is not whether sugar is healthy. It is whether “sugar-free”…
ASCO 2026: Are we overtreating cancer?
ASCO 2026: Why oncology is also paying attention to GLP-1 medicines
AI Pathology Moves From Demo to Workflow
AlphaGenome Makes Variant Interpretation Political
The AMR Pipeline Is Too Thin for the Threat Ahead
TB Diagnosis Moves Closer to the Patient
Hepatitis Elimination Is Still Losing Patients Before Diagnosis
Diabetic Eye Screening Is Becoming Risk-Based
Abu Dhabi Puts Rare Eye Gene Therapy on the Regional Map
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.